8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): November 14, 2006


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



            Delaware                      1-14120                 52-1611421
        (State or other           (Commission File Number)     (I.R.S. Employer
 jurisdiction of incorporation)                              Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))






Item 2.02.  Results of Operations and Financial Condition

On November 14, 2006, Blonder Tongue  Laboratories,  Inc. issued a press release
announcing its unaudited financial results for the third quarter ended September
30, 2006. A copy of the press release is attached to this Report as Exhibit 99.1
and is  incorporated  herein by  reference.  The  information  disclosed in this
report,  including  Exhibit 99.1  hereto,  is being  furnished  and shall not be
deemed  "filed" for  purposes of Section 18 of the  Securities  Exchange  Act of
1934.

Item 9.01.  Financial Statements and Exhibits

(a)      Not applicable


(b)      Not applicable


(c)      Not applicable


(d)      The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated November 14, 2006.







                                       2



                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By: /s/ Eric Skolnik
                                         Eric Skolnik
                                         Senior Vice President and
                                         Chief Financial Officer

Date: November 14, 2006















                                  EXHIBIT INDEX


         Exhibit No.                                 Description

         Exhibit 99.1              Press Release of Blonder Tongue Laboratories,
                                   Inc.  dated  November 14, 2006  regarding its
                                   unaudited  financial  results  for  the third
                                   quarter ended September 30, 2006.

EX-99

[LOGO]


                                                             One Jake Brown Road
                                                                   P.O. Box 1000
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353


   FOR IMMEDIATE RELEASE                   CONTACT:      James A. Luksch
                                                         Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000

                    BLONDER TONGUE REPORTS 2006 THIRD RESULTS

OLD BRIDGE, NEW JERSEY,  November 14, 2006 - Blonder Tongue  Laboratories,  Inc.
(AMEX: "BDR") today reported net sales of $9,578,000 for the third quarter 2006,
a 0.9  percent  decrease  over net  sales of  $9,666,000  reported  in the third
quarter 2005. The decrease in sales is attributed to a decrease in  interdiction
product  sales offset by an increase in fiber and core product  sales.  Sales of
interdiction  products  were  $319,000 and $733,000 and sales of fiber  products
were $647,000 and $274,000 in the third quarter of 2006 and 2005,  respectively.
Net sales increased $1,634,000, or 5.8%, to $29,977,000 in the first nine months
of 2006 from $28,343,000 in the first nine months of 2005. The increase in sales
is primarily attributed to an increase in digital, fiber and core product sales.
Digital  product sales were  $3,714,000  and  $3,374,000 and fiber product sales
were  $1,403,000  and  $812,000  in the  first  nine  months  of 2006 and  2005,
respectively.

Net income for the third quarter 2006 was $175,000, or $0.02 per share, compared
to a net loss of  $3,516,000 or ($0.44) per share for the  comparable  period in
2005.  Net loss for the nine months ended  September  30, 2006 was  $37,000,  or
breakeven  per share,  compared to a net loss of $5,047,000 or ($0.63) per share
for the comparable period in 2005.

Commenting on the third quarter 2006 results,  James A. Luksch,  Chief Executive
Officer,  said,  "The comparable  quarter-to-quarter  sales  performance,  being
relatively flat, is buoyed by the year-to-date  sales  improvement."  Mr. Luksch
continued,  "The  elimination of certain  non-core  business units  continues to
progress.  With the disposal of our interest in Blonder Tongue Telephone and the
planned  divestiture of BDR Broadband,  our Texas-based private cable system, we
expect an annual  improvement to our net income of  approximately  $600,000.  In
addition,  the anticipated  sale of selected Company patent rights should result
in net proceeds of approximately $2,000,000."

Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband service providers. The Company designs,  manufactures,  and supplies a
comprehensive line of equipment to deliver video (analog & digital),  high speed
data and voice  services  over  integrated  coaxial  and fiber  optic  broadband
networks today and over packet based,  Internet protocol networks of the future.
For more information regarding Blonder Tongue or its products,  please visit the
Company's Web site at  www.blondertongue.com  or contact the Company directly at
(732) 679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2005 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission are  incorporated  herein by reference.  The
words  "believe",  "expect",  "anticipate",  "should",  "project",  and  similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis only as of the date hereof.  Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  There can be no assurance
that Blonder  Tongue will be  successful  in its efforts to sell BDR  Broadband.
Blonder Tongue's actual results may differ from the anticipated results or other
expectations expressed in Blonder Tongue's "forward-looking" statements.

                                     -MORE-



                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                  Three months ended           Nine months ended
                                     September 30,               September 30,
                                  ------------------     -----------------------
                                   2006     2005          2006      2005

Net sales                          $9,578   $9,666       $29,977   $28,343
Gross profit (loss)                 3,755      (53)       10,672     5,333
Earnings (loss) from operations       345   (3,271)          612    (4,215)
Net earnings (loss)                   175   (3,516)          (37)   (5,047)
Net earnings (loss) per share:
   Basic                             $0.02                $  -      $(0.63)
                                             $(0.44)
                                     $0.02                $  -      $(0.63)
Diluted                                      $(0.44)
Weighted average
 shares outstanding:
   Basic                            7,515    8,015         7,845     8,015
   Diluted                          7,515    8,015         7,845     8,015






                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                          September 30, 2006   December 31, 2005
                                              (unaudited)

Current assets                                   $14,545             $15,144
Property, plant, and equipment, net                5,790               6,184
Total assets                                      30,533              32,864
Current liabilities                                6,664               8,036
Long-term liabilities                              3,124               3,329
Stockholders' equity                              20,745              21,499

Total liabilities and stockholders' equity       $30,533             $32,864